Literature DB >> 10789827

Intracellular signals coupled to muscarinic acetylcholine receptor activation in cerebral frontal cortex from hypoxic mice.

T G Borda1, A M Genaro, G Cremaschi.   

Abstract

1. The aim of the present work was to determine hypoxia-induced modifications in the cascade of intracellular events coupled to muscarinic acetylcholine receptor (mAChR) activation in brain. For this purpose, enzymatic activities were measured on normoxically incubated frontal cortical slices from mice exposed to hypobaric hypoxia for 72 hr. 2. We found that hypoxia induced alterations in several cerebral enzymatic basal activities: it increased nitric oxide synthase (NOS), but it decreased both membrane protein kinase C (PKC) and phospholipase C activities. 3. The mAChR agonist carbachol was found to increase phosphoinositide hydrolysis to greater values in hypoxic tissues than those found in normoxic conditions. Furthermore, a greater translocation of PKC in response to carbachol was observed in hypoxic tissues than in normoxic ones. 4. Besides, carbachol induced a drastic reduction of NOS activity in hypoxic brains, at concentrations that stimulated this enzyme activity in normoxic preparations. In the latter, inhibition is obtained only with high concentrations of the cholinergic muscarinic agonist. 5. These results pointed to a carbachol-mediated mAChR hyperactivity induced by hypoxic insult. 6. The possibility that these effects would account for a compensatory mechanism to diminish NOS hyperactivity, probably protecting for NO neurotoxic action in hypoxic brain, is also discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10789827     DOI: 10.1023/a:1007053907569

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  32 in total

1.  Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia.

Authors:  P Kuppusamy; S T Ohnishi; Y Numagami; T Ohnishi; J L Zweier
Journal:  J Cereb Blood Flow Metab       Date:  1995-11       Impact factor: 6.200

2.  Substrate-dependent inhibition of protein kinase C by specific inhibitors.

Authors:  M Junco; M J Díaz-Guerra; L Boscá
Journal:  FEBS Lett       Date:  1990-04-09       Impact factor: 4.124

Review 3.  Neurofilaments: structure, metabolism and implications in disease.

Authors:  W W Schlaepfer
Journal:  J Neuropathol Exp Neurol       Date:  1987-03       Impact factor: 3.685

4.  Separation of [3H] inositol monophosphates and [3H] inositol on silica gel glass-fiber sheets.

Authors:  M Hokin-Neaverson; K Sadeghian
Journal:  J Chromatogr       Date:  1976-05-26

5.  Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development.

Authors:  E Southam; S J East; J Garthwaite
Journal:  J Neurochem       Date:  1991-06       Impact factor: 5.372

6.  Effects of oxygen depletion on norepinephrine- and carbachol-stimulated phosphoinositide turnover in rat brain slices.

Authors:  H Ninomiya; T Taniguchi; M Fujiwara; M Kameyama
Journal:  J Neurochem       Date:  1989-07       Impact factor: 5.372

7.  Brain lactic acidosis and ischemic cell damage: 1. Biochemistry and neurophysiology.

Authors:  S Rehncrona; I Rosén; B K Siesjö
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

8.  Stimulus-dependent inhibition of platelet aggregation by the protein kinase C inhibitors polymyxin B, H-7 and staurosporine.

Authors:  C Schächtele; R Seifert; H Osswald
Journal:  Biochem Biophys Res Commun       Date:  1988-02-29       Impact factor: 3.575

9.  A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death.

Authors:  I Hajimohammadreza; A W Probert; L L Coughenour; S A Borosky; F W Marcoux; P A Boxer; K K Wang
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

Review 10.  Cellular alterations associated with perinatal asphyxia.

Authors:  M V Johnston
Journal:  Clin Invest Med       Date:  1993-04       Impact factor: 0.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.